Mint Ventures led the investment round with co-investment from Alma Angels and Lifted Ventures.
"We are thrilled to support My Bliss and their visionary team. Their commitment to improving women’s health through evidence-based innovation aligns perfectly with our mission to back diverse founders who are changing the world for the better. We believe My Bliss is poised to make a significant difference to women’s health, and we’re excited to be part of their journey."
The financing round was led by Lunar Ventures to support product commercialisation and clinical development.
"Menstruation is known as the fifth vital sign, but has historically been overlooked by the wearable sector, leaving millions without the data they need to understand and advocate for their own bodies. We envision a future where menstrual health is measured and understood as comprehensively as cardiovascular or metabolic health, giving people access to objective, actionable insights to better manage their health and wellbeing."
The pre-seed round was backed by RAW Ventures and Cedars-Sinai Ventures to fund clinical deployment and regulatory approvals.
"We’re focused on leveraging the unique capabilities of ultrasound and developing solutions to make it smarter, faster, and more reliable, with clinicians at the centre of that transformation. This trial will assess the effectiveness of FraiyaScan in real world conditions. Importantly, the frontline staff and patient feedback will help us to understand the acceptability of the technology, where time-pressured scans, staffing gaps, and service variability, that can affect outcomes, may also impact the performance and adoption of AI-based innovations."
— Jackie Matthew, chief medical officer and clinical academic sonographer
The seed round was co-led by Creator Fund and LocalGlobe to help the biotech startup move its egg-quality treatment toward the clinic.
"Ovo Labs’ mission is to make the dream of parenthood a reality for millions of couples who struggle to conceive. By helping to increase the number of viable eggs, we aim to extend the reproductive window, empowering more couples to have children at a time that feels right to them. Ovo Labs’ technology also offers a potential solution for declining birth rates, which is a trend observed in many countries worldwide."
The funding round was led by Equity Gap with co-investment from Scottish Enterprise and support from Lifted Ventures.
"Lifted Ventures immediately understood the challenges our product addresses for women and recognized the potential of the market we’re targeting. Their members are more than investors – they bring invaluable networks and skillsets that are often difficult to secure. I’ve been hugely impressed by their enthusiasm, capability, and commitment, especially in encouraging more female investors into equity investing."